Compare RGEN & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | RRC |
|---|---|---|
| Founded | 1981 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 10.1B |
| IPO Year | 1995 | 1996 |
| Metric | RGEN | RRC |
|---|---|---|
| Price | $115.11 | $40.99 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 18 |
| Target Price | ★ $167.67 | $43.67 |
| AVG Volume (30 Days) | 1.0M | ★ 3.2M |
| Earning Date | 05-05-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | ★ 286.96 | 151.38 |
| EPS | 0.15 | ★ 1.44 |
| Revenue | $141,236,000.00 | ★ $3,115,515,000.00 |
| Revenue This Year | $14.30 | $15.60 |
| Revenue Next Year | $14.52 | $9.73 |
| P/E Ratio | $775.23 | ★ $28.49 |
| Revenue Growth | ★ 35.10 | 28.90 |
| 52 Week Low | $109.50 | $32.60 |
| 52 Week High | $175.77 | $48.31 |
| Indicator | RGEN | RRC |
|---|---|---|
| Relative Strength Index (RSI) | 41.71 | 41.45 |
| Support Level | $111.02 | $40.29 |
| Resistance Level | $130.12 | $44.24 |
| Average True Range (ATR) | 6.04 | 1.02 |
| MACD | -0.36 | -0.21 |
| Stochastic Oscillator | 22.45 | 25.31 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.